Drug Shortage Report for NOLVADEX-D TAB 20MG

Last updated on 2019-12-06 History
Report ID 94235
Drug Identification Number 02048485
Brand name NOLVADEX-D TAB 20MG
Common or Proper name tamoxifen citrate
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) TAMOXIFEN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 x 30
ATC code L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-09-26
Actual start date 2019-09-26
Estimated end date 2020-06-30
Actual end date
Shortage status Actual shortage
Updated date 2019-12-06
Company comments Limited supply available
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-12-06 French Compare
v12 2019-12-06 English Compare
v11 2019-11-15 French Compare
v10 2019-11-15 English Compare
v9 2019-10-31 French Compare
v8 2019-10-31 English Compare
v7 2019-09-27 English Compare
v6 2019-09-26 French Compare
v5 2019-09-26 English Compare
v4 2019-09-20 French Compare
v3 2019-09-20 English Compare
v2 2019-09-18 French Compare
v1 2019-09-18 English Compare